1. Home
  2. ASTI vs KYNB Comparison

ASTI vs KYNB Comparison

Compare ASTI & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

N/A

Current Price

$1.54

Market Cap

30.0M

Sector

Technology

ML Signal

N/A

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$3.73

Market Cap

32.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTI
KYNB
Founded
2005
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
32.8M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ASTI
KYNB
Price
$1.54
$3.73
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $38.50
AVG Volume (30 Days)
★ 231.0K
23.3K
Earning Date
11-06-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
70.23
★ 9552.08
EPS
★ N/A
N/A
Revenue
★ $10,398,149.00
$6,440,000.00
Revenue This Year
$987.62
N/A
Revenue Next Year
$2,579.52
$14.12
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 163.25
N/A
52 Week Low
$1.40
$3.50
52 Week High
$9.87
$9.66

Technical Indicators

Market Signals
Indicator
ASTI
KYNB
Relative Strength Index (RSI) 38.06 27.82
Support Level N/A N/A
Resistance Level $1.84 $7.41
Average True Range (ATR) 0.17 0.39
MACD 0.03 -0.02
Stochastic Oscillator 29.79 15.72

Price Performance

Historical Comparison
ASTI
KYNB

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: